242 related articles for article (PubMed ID: 23429005)
21. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
22. Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy.
Giammanco GM; Bechini A; Urone N; Bonura F; Li Muli S; De Grazia S; Bellini I; Tiscione E; Boccalini S; Nastasi A
Hum Vaccin Immunother; 2018; 14(9):2248-2253. PubMed ID: 29771600
[TBL] [Abstract][Full Text] [Related]
23. Sero-survey of polio antibodies and quality of acute flaccid paralysis surveillance in Chongqing, China: A cross-sectional study.
Xu J; Kuang S; Rong R; Zhang Y; Tang W; Wang Q
Medicine (Baltimore); 2020 Jul; 99(31):e21298. PubMed ID: 32756110
[TBL] [Abstract][Full Text] [Related]
24. Immunity status against poliomyelitis in young migrants: a seroprevalence study.
Veronesi L; Colucci ME; Capobianco E; Bracchi MT; Zoni R; Palandri L; Affanni P
Acta Biomed; 2019 Sep; 90(9-S):28-34. PubMed ID: 31517887
[TBL] [Abstract][Full Text] [Related]
25. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
[TBL] [Abstract][Full Text] [Related]
26. Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine.
Sutter RW; Patriarca PA; Suleiman AJ; Pallansch MA; Zell ER; Malankar PG; Brogan S; al-Ghassani AA; el-Bualy MS
Int J Epidemiol; 1993 Oct; 22(5):936-44. PubMed ID: 8282476
[TBL] [Abstract][Full Text] [Related]
27. Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan.
Saleem AF; Mach O; Yousafzai MT; Khan A; Weldon WC; Oberste MS; Sutter RW; Zaidi AKM
Vaccine; 2017 May; 35(24):3209-3214. PubMed ID: 28479178
[TBL] [Abstract][Full Text] [Related]
28. Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study.
Bianchi FP; Larocca AMV; Bozzi A; Spinelli G; Germinario CA; Tafuri S; Stefanizzi P
Vaccine; 2021 May; 39(22):2989-2994. PubMed ID: 33933314
[TBL] [Abstract][Full Text] [Related]
29. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
Giwa FJ; Olayinka AT; Ogunshola FT
Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
[TBL] [Abstract][Full Text] [Related]
31. Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016.
Ahmad M; Verma H; Kunwar A; Soni S; Sinha U; Gawande M; Sethi R; Nalavade U; Sharma D; Bhatnagar P; Bahl S; Deshpande J
Int J Infect Dis; 2021 Jan; 102():337-343. PubMed ID: 33130206
[TBL] [Abstract][Full Text] [Related]
32. Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria.
Iliyasu Z; Verma H; Craig KT; Nwaze E; Ahmad-Shehu A; Jibir BW; Gwarzo GD; Gajida AU; Weldon WC; Steven Oberste M; Takane M; Mkanda P; Muhammad AJG; Sutter RW
Vaccine; 2016 Sep; 34(42):5125-5131. PubMed ID: 27591950
[TBL] [Abstract][Full Text] [Related]
33. Risk of polio reintroduction to border regions of Islamic Republic of Iran: seroprevalence study of children with at least 5 doses of oral polio vaccine.
Izadi S; Shahmahmoodi S; Zahraei SM; Dorostkar F; Majdzadeh R
East Mediterr Health J; 2014 Jun; 20(5):287-94. PubMed ID: 24952285
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.
Pírez MC; Olivera I; Diabarboure H; Montano A; Barañano R; Badía F; Bonnet MC
Vaccine; 2009 May; 27(20):2689-94. PubMed ID: 19428880
[TBL] [Abstract][Full Text] [Related]
35. Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants.
Kaliappan SP; Venugopal S; Giri S; Praharaj I; Karthikeyan AS; Babji S; John J; Muliyil J; Grassly N; Kang G
Vaccine; 2016 Sep; 34(41):4979-4984. PubMed ID: 27566901
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.
Estívariz CF; Jafari H; Sutter RW; John TJ; Jain V; Agarwal A; Verma H; Pallansch MA; Singh AP; Guirguis S; Awale J; Burton A; Bahl S; Chatterjee A; Aylward RB
Lancet Infect Dis; 2012 Feb; 12(2):128-35. PubMed ID: 22071249
[TBL] [Abstract][Full Text] [Related]
37. The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.
Cardemil CV; Estivariz C; Shrestha L; Sherchand JB; Sharma A; Gary HE; Oberste MS; Weldon WC; Bowen MD; Vinjé J; Schluter WW; Anand A; Mach O; Chu SY
Vaccine; 2016 May; 34(22):2519-26. PubMed ID: 27085172
[TBL] [Abstract][Full Text] [Related]
38. Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial.
Mir F; Quadri F; Mach O; Ahmed I; Bhatti Z; Khan A; Rehman NU; Durry E; Salama M; Oberste SM; Weldon WC; Sutter RW; Zaidi AK
Lancet Infect Dis; 2015 Aug; 15(8):889-97. PubMed ID: 26093979
[TBL] [Abstract][Full Text] [Related]
39. Effect of diarrhea on the humoral response to oral polio vaccination.
Myaux JA; Unicomb L; Besser RE; Modlin JF; Uzma A; Islam AM; Santosham M
Pediatr Infect Dis J; 1996 Mar; 15(3):204-9. PubMed ID: 8852907
[TBL] [Abstract][Full Text] [Related]
40. Virological and serological studies on poliomyelitis in Karachi, Pakistan. I. Outbreaks in 1990-91.
Isomura S; Mubina A; Dure-Samin A; Isihara Y; Sakae K; Yamashita T; Nishio O; Ahmed A
Acta Paediatr Jpn; 1993 Oct; 35(5):382-6. PubMed ID: 8256620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
